On the occasion of World Hepatitis B Day, established annually on 28 July, the United Nations and governments are reminded to act together to curb the epidemic, primarily by promoting vaccination and diagnosis. Treat and prevent people from developing cirrhosis and liver cancer. Hepatitis B is a viral disease that is mainly transmitted through the sexual and parental routes (close distance) of people with hepatitis B.
Dr. César Cabezas Sánchez, an Ayacuchano native who has been noted for his work throughout his career, was born in the province of Vantaa, in San Marcos Completed medical higher education at Mayor National University, he is an Infectious Disease Specialist He holds a Masters in Medicine and a Doctorate in Public Health. He served as director of the National Institutes of Health twice, the last time in 2020 during the COVID-19 pandemic.
During his lifetime, he conducted several studies to better understand hepatitis B disease, which today form the basis of the scientific literature, and with the support of many other Very prevalent disease in the territory as well as in the province of Vantaa. and Lamar (VRAEM).
Located in the Andean region of Peru, Ayacucho is at the center of the country’s hepatitis response. In the early 1990s, hepatitis B virus and hepatitis D virus threatened public health in the region. For example, in the city of Vantaa, in the province of Ayacucho, about 8% of the deaths in the city were linked to the disease.
Efforts to reverse hepatitis, especially in children, have now made Ayacucho a role model for the Americas. To address this issue, the Peruvian National Institutes of Health, with the support of the Pan American Health Organization (PAHO), the World Health Organization (WHO), and with the active participation of community-based organizations, conducted a pilot to evaluate the Effectiveness and feasibility of an infant immunization schedule against hepatitis B virus.
On the back of this new evidence, the Peruvian National Immunization Program included HBV vaccination in its annual schedule and achieved universal coverage throughout the country in 2003. Currently, there are no registered cases of HBV infection in Vantaa. Hepatitis B in children under 20 years old.
Despite the success of childhood immunization programs, other adult populations still have high rates of chronic hepatitis. In 2018, 30% of all reported hepatitis B cases in Peru were from Ayacucho. Although HBV can be prevented through vaccination, people who are already infected with HBV require lifelong treatment.